Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Kallioniemi

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Leukemia|November 1, 2016
Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemiaP N Ojamies, M Kontro, H Edgren, et al.
Oncogene|November 29, 2011
Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasionM Björkman, P Östling, V Härmä, et al.
Blood Cancer Journal|December 10, 2013
Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activationE I Andersson, H L M Rajala, S Eldfors, et al.
Leukemia|November 12, 2016
Enhanced sensitivity to glucocorticoids in cytarabine-resistant AMLD Malani, A Murumägi, B Yadav, et al.
Blood Cancer Journal|May 2, 2015
Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testingP O Pietarinen, T Pemovska, M Kontro, et al.
Oncogene|August 18, 2009
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell linesS-K Leivonen, R Mäkelä, P Ostling, et al.
Oncogene|November 27, 2012
Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβS Jin, A P Mutvei, I V Chivukula, et al.
Leukemia|August 9, 2016
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemiaM Kontro, A Kumar, M M Majumder, et al.
Leukemia|February 28, 2014
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemiaM Kontro, H Kuusanmäki, S Eldfors, et al.
Leukemia|August 15, 2017
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profilingE I Andersson, S Pützer, B Yadav, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Leukemia|November 1, 2016
Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemiaP N Ojamies, M Kontro, H Edgren, et al.
Oncogene|November 29, 2011
Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasionM Björkman, P Östling, V Härmä, et al.
Blood Cancer Journal|December 10, 2013
Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activationE I Andersson, H L M Rajala, S Eldfors, et al.
Leukemia|November 12, 2016
Enhanced sensitivity to glucocorticoids in cytarabine-resistant AMLD Malani, A Murumägi, B Yadav, et al.
Blood Cancer Journal|May 2, 2015
Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testingP O Pietarinen, T Pemovska, M Kontro, et al.
Oncogene|August 18, 2009
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell linesS-K Leivonen, R Mäkelä, P Ostling, et al.
Oncogene|November 27, 2012
Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβS Jin, A P Mutvei, I V Chivukula, et al.
Leukemia|August 9, 2016
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemiaM Kontro, A Kumar, M M Majumder, et al.
Leukemia|February 28, 2014
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemiaM Kontro, H Kuusanmäki, S Eldfors, et al.
Leukemia|August 15, 2017
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profilingE I Andersson, S Pützer, B Yadav, et al.
Pageof 3